First, you have no idea on how to build a company from a
First, you have no idea on how to build a company from a small handful of people to a large company in less than a year. it is a struggle to say the least when the majority of your employees have been hired in the last 6-8 months and have to become a successful operating unit. yes its extremely expensive but the challenges of creating one culture and operating efficiently in a very short time is extremely difficult.
second i have been a COO of a fast growing company. it is very challenging. you dont hire a lot of sales people and all of a sudden they are very effective. its takes a year to make a rep successful selling your product , especially in this business. the reps from the other companies from big pharma are tough to compete with when you are trying to get reps up to speed on your drug. this is not a small task. you actually lose momentum during this period regardless of how good your drug is.
i can run a list as long as your arm on the reasons not to do this including the current skillsets of management. It takes a lot of business savvy: not science savvy to pull it off.
We differ in our opinion. thats fine. But i think you are looking at sheer sales dollars and those wont come to fruition without a pharma partner with a lot of reps ready and who have the sales relationships already to pull it off. its difficult to say the least. We can have this disucssion a year from now when we actually have a product out the door . but i guarantee you, Dr. Kelly doesnt want to build his own sales team
13
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Bold Gathering with Lofty Goals Ever watch a room of world leaders debate the finer nuances of sustainable infrastructure? That's something Singapore pulled off on September 6, 2026, with the Second Global Business Summit on Belt and Road Infrastructure Investment. These aren't just any ordinary suits sitting around in a conference room. We're talking about a dynamic...
Continue Reading
Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...
Continue Reading
EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...
Continue Reading
Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...
Continue Reading
A New Kind of Movement Imagine a campaign not bound by age or geography but united by a shared mission. Generation Smile, freshly launched by the FDI World Dental Federation in Prague, is just that kind of uprising. This initiative redefines existing approaches to oral health, pushing beyond the boundaries of mere dental care to emphasize the integral role oral health...
Continue Reading
Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...
Continue Reading
While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...
Continue Reading
Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...
Continue Reading
Analyzing China's Impact on Global Markets Think of China's manufacturing clout and you're likely to picture booming factories, relentless steel, and smoke-churning industries reshaping the global chessboard. But here's the kicker: are they swallowing up room for others, or paving the way for their growth? It’s this debate that took the spotlight at the Asia-Pacific...
Continue Reading
AI and Displays: A Match Made in Tech Heaven Every so often, a company stands up at a tech fair and gives a glimpse into the next chapter of living, as TCL did at IFA 2026. This time, they're not just talking about screens; they're weaving them into the fabric of everyday life alongside AI capabilities. From sporting arenas to your living room, it's a vision of what could...
Continue Reading
Top 5 Most Recently Viewed Articles
Anika Therapeutics Reports Q3 2024 Financials In a significant move, Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in joint preservation, has reported its financial results for the third quarter ending September 30, 2024. This release follows the company’s strategic decisions to pivot its focus towards high-growth segments within the orthopedic industry. Key...
Continue Reading
Red Cat's Strategic Shift in Drone Technology Funding Red Cat Holdings, Inc. (Nasdaq: RCAT), a leader in drone technology designed for military, government, and commercial applications, has recently announced a significant financial move. The company secured an agreement for up to $20 million in debt financing, with the initial tranche of $16.5 million already completed....
Continue Reading
Understanding Alamos Gold's Investment Potential Alamos Gold (NYSE: AGI) has shown impressive performance in the market over the past five years, boasting an annualized return of 27.3%. This strong growth has allowed the company to outperform the market by a significant margin of 12.72% annually. With a current market capitalization of approximately $8.42 billion, Alamos...
Continue Reading
Phemex Launches 24/7 TradFi Futures Trading Phemex, a user-focused cryptocurrency exchange, has recently announced an exciting development in trading: the introduction of their traditional finance (TradFi) futures trading. This innovative offering allows users to access a variety of traditional financial assets, including stocks and precious metals, at any time of the day...
Continue Reading
Kraig Biocraft Laboratories Reaches Remarkable Production Goal Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) has recently made headlines by completing a noteworthy production cycle that resulted in the delivery of over one million BAM-1 Alpha hybrid eggs. This significant achievement marks a pivotal moment for the company as they look to amplify their production...
Continue Reading